1. Home
  2. PPBT vs PLAG Comparison

PPBT vs PLAG Comparison

Compare PPBT & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • PLAG
  • Stock Information
  • Founded
  • PPBT 2010
  • PLAG 1986
  • Country
  • PPBT Israel
  • PLAG United States
  • Employees
  • PPBT N/A
  • PLAG N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • PPBT Health Care
  • PLAG Consumer Staples
  • Exchange
  • PPBT Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • PPBT 6.3M
  • PLAG 6.6M
  • IPO Year
  • PPBT N/A
  • PLAG N/A
  • Fundamental
  • Price
  • PPBT $2.45
  • PLAG $0.83
  • Analyst Decision
  • PPBT Strong Buy
  • PLAG
  • Analyst Count
  • PPBT 1
  • PLAG 0
  • Target Price
  • PPBT $33.00
  • PLAG N/A
  • AVG Volume (30 Days)
  • PPBT 23.8K
  • PLAG 808.9K
  • Earning Date
  • PPBT 08-15-2025
  • PLAG 08-13-2025
  • Dividend Yield
  • PPBT N/A
  • PLAG N/A
  • EPS Growth
  • PPBT N/A
  • PLAG N/A
  • EPS
  • PPBT N/A
  • PLAG N/A
  • Revenue
  • PPBT N/A
  • PLAG $6,066,143.00
  • Revenue This Year
  • PPBT N/A
  • PLAG N/A
  • Revenue Next Year
  • PPBT N/A
  • PLAG N/A
  • P/E Ratio
  • PPBT N/A
  • PLAG N/A
  • Revenue Growth
  • PPBT N/A
  • PLAG N/A
  • 52 Week Low
  • PPBT $2.00
  • PLAG $0.47
  • 52 Week High
  • PPBT $13.95
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 47.68
  • PLAG 35.79
  • Support Level
  • PPBT $2.26
  • PLAG $0.75
  • Resistance Level
  • PPBT $2.45
  • PLAG $0.92
  • Average True Range (ATR)
  • PPBT 0.14
  • PLAG 0.33
  • MACD
  • PPBT -0.01
  • PLAG -0.10
  • Stochastic Oscillator
  • PPBT 44.12
  • PLAG 15.58

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: